Binocrit, 3000 me/0.3 ml 3 ml syringes 6 pcs

Erythropoietin is a glycoprotein that stimulates erythropoiesis, activates mitosis and maturation of erythrocytes from erythrocyte precursor cells.

Indications

Anemia – Anemia in adults and children due to chronic renal failure, including: – Anemia due to chronic renal failure in children and adults on hemodialysis and in adults on peritoneal dialysis; – Severe anemia of renal genesis accompanied by clinical symptoms in adults with renal failure who have not yet had hemodialysis;

Active ingredient

Epoetin alfa

How to take, the dosage

Intravenously, subcutaneously. Treatment with Binocrit should be carried out under supervision of a specialist with appropriate qualification and experience in treatment of patients who are indicated for therapy with erythropoiesis stimulants.

Interaction

There are no data on interaction of epoetin alfa with other drugs. However, when concomitant use with cyclosporine, interaction is possible, because the drug binds to red blood cells.

Special Instructions

BP should be checked and closely monitored in all patients when Binocrit is prescribed. Caution should be used with epoetin alfa in patients with hypertension if they are not receiving the necessary treatment, the prescribed treatment is inadequate, or the hypertension is poorly controlled.

Synopsis

Solution for intravenous and subcutaneous administration

Contraindications

Hypersensitivity to the active substance and excipients that make up the drug;

Side effects

The side effects shown below are classified according to organ and system classification and by frequency of occurrence: very common (≥1/10); common (≥1/100-

Overdose

The therapeutic range of the drug is wide.

Similarities

Eralfon syringes